Not logged in Share Save
Share Save
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma Mcgillivray, Erin; Ashouri, Karam; Chatziioannou, Eftychia; Gallegos, Jesus Antonio Ocejo; Zarka, Jabra; Kechter, Jacob; Hwang, Angelina S.; Zhang, Kevin; Barros, Milton; Yeh, Justin; Okazaki, Ian; Crocker, Andrew B.; Maeda, Takuya; Park, Soo J.; Choi, Jacob; Andreoli, Mia; Darwish, Tarneem; Savage, David J.; Kim, Kevin B.; Gupta, Jayant; Shen, James; Shirai, Keisuke; Choi, April; Pai, Lori; Vazquez, Vinicius de Lima; Moser, Justin; Amaral, Teresa; Aya, Leonel F. Hernandez; Lutzky, Jose; Najjar, Yana G.; Costello, Collin M.; Mangold, Aaron R.; Bhatia, Shailender; Gibney, Geoffrey T.; Farma, Jeffrey M.; Daniels, Gregory A.; Sosman, Jeffrey; Chandra, Sunandana; Mangla, Ankit; Bollin, Kathryn; Possik, Patricia Abrao; Robles-Espinoza, Carla Daniela; Ito, Fumito; In, Gino K. Share Save
Share Save
Type II RAF inhibitor tovorafenib in recurrent/refractory (R/R) melanoma or other solid tumors with RAF fusions and/or RAF1 amplification Vieito, M.; Garralda, E.; Mehmi, I.; Marqueste, C. Gaudy; O'Neil, B. H.; Medina, T. M.; Body, A.; Arance, A. M.; Kummar, S.; Najjar, Y. G.; Bedard, P. L.; Chu, C.; McKenna, C.; Hume, S.; Kopp, L. M.; Lee, J. Share Save
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023) Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; V. Long, Georgina; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. Share Save
Initial results from a phase 1a/1b study of STK-012, a first-in-class α/β IL-2 receptor biased partial agonist in advanced solid tumors (NCT05098132) Izar, Benjamin; Zamarin, Dmitriy; Spigel, David R.; Hoimes, Christopher J.; McDermott, David F.; Sehgal, Kartik; Najjar, Yana G.; Schoenfeld, Adam J.; Garon, Edward B.; Sullivan, Ryan J.; Henick, Brian S.; Leal, Ticiana A.; Hurwitz, Michael E.; McKay, Rana R.; Busby, Natalie; Mehta-Damani, Anita; Azrilevich, Alex; Tran, Tony; Rizvi, Naiyer; Oft, Martin; Spira, Alexander I. Share Save
Share Save
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; Long, Georgina L.; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. Share Save
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA) Wei, Alexander Z.; Chen, Lanyi N.; Orloff, Marlana; Ariyan, Charlotte E.; Asgari, Maryam; Barker, Christopher A.; Buchbinder, Elizabeth; Chandra, Sunandana; Couts, Kasey; Frumovitz, Michael M.; Futreal, Andrew; Gershenwald, Jeffrey E.; Hanna, Ehab Y.; Izar, Benjamin; Leblanc, Amy K.; Leitao, Mario M.; Lipson, Evan J.; Liu, David; Mccarter, Martin; Mcquade, Jennifer L.; Najjar, Yana; Rapisuwon, Suthee; Selig, Sara; Shoushtari, Alexander N.; Yeh, Iwei; Schwartz, Gary K.; Guo, Jun; Patel, Sapna P.; Carvajal, Richard D. Share Save
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant checkpoint inhibitor and subsequent surgical resection in patients with BRAF V600-mutated stage III/IV melanoma Weber, J. S.; Haque, W.; Markovic, S. N.; Salama, A. K. S.; Mehmi, I.; Sullivan, R. J.; Najjar, Y. G.; van Akkooi, A. C. J.; Menzies, A. M.; Long, G. V.; Taylor, A. M.; Haanen, J. B. A. G.; Zijlker, L.; Davis, K.; Karanth, S.; Shah, R.; Connolly, L.; Norton, D. Share Save
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes Karapetyan, Lilit; AbuShukair, Hassan M.; Li, Aofei; Knight, Andrew; Al Bzour, Ayah Nedal; MacFawn, Ian P.; Thompson, Zachary J.; Chen, Ann; Yang, Xi; Dadey, Rebekah; Karunamurthy, Arivarasan; De Stefano, Danielle Vargas; Sander, Cindy; Kunning, Sheryl R.; Najjar, Yana G.; Davar, Diwakar; Luke, Jason J.; Gooding, William; Bruno, Tullia C.; Kirkwood, John M.; Storkus, Walter J. Share Save
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study Augustin, Ryan C.; Huang, Ziyu; Ding, Fei; Zhai, Shuyan; McArdle, Jennifer; Santisi, Anthony; Davis, Michael; Sander, Cindy; Davar, Diwakar; Kirkwood, John M.; Delgoffe, Greg M.; Warner, Allison Betof; Najjar, Yana G. Share Save
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy Pickering, Chad; Aiyetan, Paul; Xu, Gege; Mitchell, Alan; Rice, Rachel; Najjar, Yana G. G.; Markowitz, Joseph; Ebert, Lisa M. M.; Brown, Michael P. P.; Tapia-Rico, Gonzalo; Frederick, Dennie; Cong, Xin; Serie, Daniel; Lindpaintner, Klaus; Schwarz, Flavio; Boland, Genevieve M. M. Share Save
First-in-class first-in-human phase 1 trial and translational study of the mono(ADP-ribose) polymerase-7 (PARP7) inhibitor RBN-2397 in patients with selected advanced solid tumors Yap, Timothy A.; Cervantes, Andres; Falchook, Gerald S.; Patel, Manish R.; Juric, Dejan; Waqar, Saiama N.; Schenk, Erin L.; Shapiro, Geoffrey; Boni, Valentina; Perez, Cesar A.; Burtness, Barbara; Najjar, Yana G.; Racca, Fabricio; Rojas, Katerin; Kuplast-Barr, Kristy; McEachern, Kristen; Samant, Manoj; Bozon, Viviana; Parasuraman, Sudha; Johnson, Melissa Share Save
Share Save
Share Save
Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis Bastacky, Melissa L.; Wang, Hong; Fortman, Dylan; Rahman, Zahra; Mascara, Gerard P.; Brenner, Timothy; Najjar, Yana G.; Luke, Jason J.; Kirkwood, John M.; Zarour, Hassane M.; Davar, Diwakar Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
